Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8507874 | Acta Pharmaceutica Sinica B | 2018 | 12 Pages |
Abstract
In this study, the biosynthetic gene cluster of chuangxinmycin (1) was firstly identified, cloned and heterologously expressed and a plausible pathway for its biosynthesis was proposed: L-tryptophan was converted to seco-chuangxinmycin (3) through a series of biochemical reaction processes and by hijacking the sulfur transfer system from primary metabolism using the cluster-situated sulfur carrier protein CxnE. Then the second C-S bond formation was achieved by the cytochrome P450 CxnD.105
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Yuanyuan Shi, Zhibo Jiang, Xingxing Li, Lijie Zuo, Xuan Lei, Liyan Yu, Linzhuan Wu, Jiandong Jiang, Bin Hong,